American Society of Hematology

2017 Continuing Conversations with the Speakers

Please check back in July 2018 to view the preliminary schedule and program for the 60th ASH Annual Meeting and Exposition.

Continuing Conversations With the Speakers sessions are informal, interactive discussions with Scientific Program speakers. These sessions are available on a first-come, first-served basis and are intended to give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic and to the opinions of experts in those particular fields. Attendees should come prepared to actively participate in the discussions.

Continuing Conversations With the Speakers on Advances in Cellular Immunotherapy for Lymphoid Malignancies

Saturday, December 9, 2017, 11:15 a.m. - 12:15 p.m.
Georgia World Congress Center, Bldg C- Lvl 1- C104

Please click here to review this session.

Join Drs. Dotti, Turtle, and Mackall to continue discussions on ways to improve the efficacy, specificity, response durability, and safety of CAR T-cell therapies for the effective treatment of lymphoid malignancies. This Continuing Conversations with the Speakers session complements the Scientific Program session on Advances in Cellular Immunotherapy for Lymphoid Malignancies and provides an increased opportunity for scientific peers to form collaborations and partnerships.

Continuing Conversations with the Speakers sessions give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic and to the opinions of experts in those particular fields. The format of these sessions is an interactive discussion for a limited audience on a first-come, first-served basis. Attendees should come prepared to actively participate in the discussions.

Chair:

Adolfo A. Ferrando, MD, PhD
Columbia University
New York, NY

Speakers:

Gianpietro Dotti, MD
University of North Carolina
Chapel Hill, NC

Cameron J. Turtle, MBBS, PhD
Fred Hutchinson Cancer Research Center
Seattle, WA

Crystal L. Mackall, MD
Stanford University
Stanford, CA

back to top

Continuing Conversations With the Speakers on Clonal Evolution in Myeloid Malignancies

Saturday, December 9, 2017, 11:45 a.m. - 12:45 p.m.
Georgia World Congress Center, Bldg C- Lvl 1- C103

Please click here to review this session.

Join Drs. Curtis, Ley, Link and Brown to continue discussing pre-clinical and clinical factors impacting clonal evolution of myeloid malignancies. This Continuing Conversations with the Speakers session complements the Joint Scientific Program session on Clonal Evolution of Myeloid Malignancies and provides an increased opportunity for scientific peers to form collaborations and partnerships.

Continuing Conversations with the Speakers sessions give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic and to the opinions of experts in those particular fields. The format of these sessions is an interactive discussion for a limited audience on a first-come, first-served basis. Attendees should come prepared to actively participate in the discussions.

Chairs:

Reuben Kapur, PhD
Indiana University School of Medicine
Indianapolis, IN

Lucy Godley, MD,PhD
University of Chicago Medical Center
Chicago, IL

Speakers:

Christina Curtis, PhD
Stanford University School of Medicine
Stanford, CA

Timothy J. Ley, MD
Washington University Medical School
Saint Louis, MO

Daniel C. Link, MD
Washington University Medical School
Saint Louis, MO

Anna L. Brown, PhD
Centre for Cancer Biology
Adelaide, Australia

back to top

Continuing Conversations With the Speakers on New Innovations in Platelet Regulation of Tumor Growth and Metastasis

Sunday, December 10, 2017, 11:15 a.m. - 12:15 p.m.
Georgia World Congress Center, Bldg C- Lvl 1- C103

Please click here to review this session. 

Join Drs. Byzova, Battinelli, and Sood to continue discussions aimed at facilitating attendees understanding of complex mechanisms involved platelet regulation and the role these mechanisms play in the development of future therapies. This Continuing Conversations with the Speakers session complements the Scientific Program session on New Innovations in Platelet Regulation of Tumor Growth and Metastasis and provides an increased opportunity for scientific peers to form collaborations and partnerships.

Continuing Conversations with the Speakers sessions give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic and to the opinions of experts in those particular fields. The format of these sessions is an interactive discussion for a limited audience on a first-come, first-served basis. Attendees should come prepared to actively participate in the discussions.

Chair:

Michael Holinstat, PhD
University of Michigan
Ann Arbor, MI

Speakers:

Tatiana V. Byzova, PhD
Cleveland Clinic Foundation
Cleveland, OH

Elisabeth M. Battinelli, MD, PhD
Brigham and Women's Hospital
Boston, MA

Anil Sood, MD
University of Texas MD Anderson Cancer Center
Houston, TX

back to top

Continuing Conversations With the Speakers on Novel Epigenetic Modifications in Cancer and Development

Sunday, December 10, 2017, 11:15 a.m. - 12:15 p.m.
Georgia World Congress Center, Bldg C- Lvl 1- C104

Please click here to review this session. 

Join Drs. Figueroa, Rao, and Lyko to continue discussions on mechanisms influencing epigenetic modifications. This Continuing Conversations with the Speakers session complements the Scientific Program session on Novel Epigenetic Modifications in Cancer and Development and provides an increased opportunity for scientific peers to form collaborations and partnerships. 

Continuing Conversations with the Speakers sessions give interested individuals, especially trainees and junior investigators, increased accessibility both to information on the topic and to the opinions of experts in those particular fields. The format of these sessions is an interactive discussion for a limited audience on a first-come, first-served basis. Attendees should come prepared to actively participate in the discussions.

Chair:

Grant A. Challen, PhD
Washington University School of Medicine
St. Louis, MO

Speakers:

Maria E. Figueroa, MD
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Miami, FL

Anjana Rao, PhD
La Jolla Institute for Allergy and Immunology
La Jolla, CA

Frank Lyko, PhD
German Cancer Research Center
Heidelberg, Germany

back to top